3-Day Countdown to Launch: Ruixin Medical to Unveil Fully Autonomous AI-Powered Robotic System for Vascular Intervention

RaysightMed Coronary Functional Measurement System AngioQFA 100 Debuts at the 2025 Oriental Conference, Leading a New Direction in One-Stop Coronary + Microcirculation Functional Assessment

Following its approval by the NMPA, the world's first AI-based coronary microcirculation IMR assessment product — RaysightMed AngioQFA — was featured in an internationally authoritative journal.

Case Analysis | RaysightMed AngioQFA 100 Consumables Successfully Achieve Clinical Use